Patents by Inventor T Senthil Kumar

T Senthil Kumar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9303016
    Abstract: The present invention relates to certain amide derivatives that have the ability to inhibit 11-?-hydroxysteroid dehydrogenase type 1 (11?-HSD-1) and which are therefore useful in the treatment of certain disorders that can be prevented or treated by inhibition of this enzyme. In addition the invention relates to the compounds, methods for their preparation, pharmaceutical compositions containing the compounds and the uses of these compounds in the treatment of certain disorders. It is expected that the compounds of the invention will find application in the treatment of conditions such as non-insulin dependent type 2 diabetes mellitus (NIDDM), insulin resistance, obesity, impaired fasting glucose, impaired glucose tolerance, lipid disorders such as dyslipidemia, hypertension and as well as other diseases and conditions.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: April 5, 2016
    Assignee: CONNEXIOS LIFE SCIENCES PVT. LTD.
    Inventors: Jagannath Madanahalli Ranganath Rao, Uppala Venkatesham, Sivanageswara Rao Doppalapudi, Bommegowda Yadaganahalli Kenchegowda, George Fernand, Jenson George, G R Madhavan, Gorle Paidapu Naidu, V. S. Naga Rajesh Kadambari, S Jagannath, R Manivannan, T Senthil Kumar, B Siva Senthil Kumar, Rayi Mallikarjuna
  • Publication number: 20150141650
    Abstract: The present invention relates to certain amide derivatives that have the ability to inhibit 11-?-hydroxysteroid dehydrogenase type 1 (11?-HSD-1) and which are therefore useful in the treatment of certain disorders that can be prevented or treated by inhibition of this enzyme. In addition the invention relates to the compounds, methods for their preparation, pharmaceutical compositions containing the compounds and the uses of these compounds in the treatment of certain disorders. It is expected that the compounds of the invention will find application in the treatment of conditions such as non-insulin dependent type 2 diabetes mellitus (NIDDM), insulin resistance, obesity, impaired fasting glucose, impaired glucose tolerance, lipid disorders such as dyslipidemia, hypertension and as well as other diseases and conditions.
    Type: Application
    Filed: December 21, 2012
    Publication date: May 21, 2015
    Inventors: Jagannath Madanahalli Ranganath Rao, Uppala Venkatesham, Sivanageswara Rao Doppalapudi, Bommegowda Yadaganahalli Kenchegowda, George Fernand, Jenson George, G R Madhavan, Gorle Paidapu Naidu, V. S. Naga Rajesh Kadambari, S Jagannath, R Manivannan, T Senthil Kumar, B Siva Senthil Kumar, Rayi Mallikarjuna